FDA approves Lospa Knee System (Corentec America) for Knee Replacement Surgery

The FDA has given clearance to market the Lospa Knee System, from Corentec America in the United States. The innovative Knee Joint Replacement System is available and offers an anatomically featured shape for both a cruciate retaining (CR) and a posterior stabilized (PS) knee within a single system. This ensures successful patient outcomes with natural knee range of motion and increased longevity of the implant. Corentec America has successfully completed a number of cases in the US using the Lospa Knee System. Corentec will unveil the Lospa Knee System, and the Company's portfolio of Hip and Knee Joint Implants at the North American Spine Society (NASS) Annual Meeting in Dallas, October 24-27.